Ultragenyx Pharmaceutical Inc. (RARE)
Market Closed
16 Oct, 08:00 PM
$
14. 54
-0.63
-4.1529%
$
1.43B Market Cap
- P/E Ratio
- Div Yield
2.92M Volume
-8.23 Eps
$ 15.17
Previous Close 
Want to track RARE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ultragenyx Pharmaceutical Inc. (RARE) Statistics
Valuation metrics
Market Cap 1.43B
Enterprise value 2.51B
Trailing P/E (ttm) -2.49
Forward P/E -1,907.31
PEG ratio 0.4
Price/Sales (ttm) 2
Price/Book (mrq) -5.09
Enterprise Value/Revenue 3.5
Enterprise Value/EBITDA -5.31
Overview
Shares outstanding 96.48M
Float 92.93M
Shares short 11.41M
% Held by insiders 0.03%
% Held by institutions 1.01%
Average volume (10 days) 3.74M
Average volume (90 days) 4.05M
Price summary
52-Week low 12.73
52-Week high 39.89
Beta 0.25
50-Day moving average 15.95
200-Day moving average 23.57
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:3
Last split Date 17 Jan 2014
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.82%
Operating margin -0.74%
Operational effectiveness
Return on assets -0.46%
Return on equity 3.92%
Income Statement
Revenue (ttm) 673M
Revenue per share (ttm) 7.04
Quarterly revenue growth (yoy) 0.26%
Gross profit (ttm) -186M
EBITDA -500M
Net income to common (ttm) -575M
Diluted EPS (ttm) -5.75
Quarterly earnings growth (yoy) 0.26%
Balance Sheet
Total cash (mrq) 680M
Total cash per share (mrq) 2.87
Total debt (mrq) 1.25B
Total Debt/Equity (mrq) -4.13
Current ratio (mrq) 1.73%
Book value per share (mrq) -2.79
Cash Flow
Cash flow statement -466M
Levered free cash flow (LFCF) -251.12M
2026 © Marketlog. All Rights Reserved.
